A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infection

Rheumatology International

Volumn 27, Issue 4, 2007, Pages 411-414

  Ideguchi, Haruko ^a   Ohno, Shigeru ^a   Ishigatsubo, Yoshiaki ^b  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Healthy subject; Human parvovirus B19; Pure red cell aplasia; Systemic lupus erythematosus

Indexed keywords

PREDNISONE;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; ERYTHEMA INFECTIOSUM; ERYTHROCYTE CONCENTRATE; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MOUTH ULCER; PARVOVIRUS; PHYSICAL EXAMINATION; POLYARTHRITIS; PRIORITY JOURNAL; PURE RED CELL ANEMIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

AGED, 80 AND OVER; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RED-CELL APLASIA, PURE;

EID: 33846314013     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-006-0227-z     Document Type: Article

References (15)

1. Young NS (1995) B19 parvovirus. Baillieres Clin Haematol 8(1):25-56
2. Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS (1987) Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 317(5):287-294
3. Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM et al (1985) Experimental parvoviral infection in humans. J Infect Dis 152(2):257-265
4. Krantz SB (1974) Pure red-cell aplasia. N Engl J Med 291(7):345-350
5. Ammus SS, Yunis AA (1987) Acquired pure red cell aplasia. Am J Hematol 24(3):311-326
6. Diamond LK, Wang WC, Alter BP (1976) Congenital hypoplastic anemia. Adv Pediatr 22:349-378
7. Atzeni F, Sarzi-Puttini P, Capsoni F, Vulpio L, Carrabba M (2003) Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin A. Clin Exp Rheumatol 21(6):759-762
8. Mitsunaka H, Tokuda M, Takahara J, Matoba K, Miyawaki S (1998) [A case of systemic lupus erythematosus with pure red cell aplasia possibly caused by persistent infection of human parvovirus B 19]. Nihon Rinsho Meneki Gakkai Kaishi 21(5):220-225
9. Suzuki T, Saito S, Hirabayashi Y, Harigae H, Ishii T, Kodera T et al (2003) Human parvovirus B19 infection during the inactive stage of systemic lupus erythematosus. Intern Med 42(6):538-540
10. Arcasoy MO, Chao NJ (2005) T-cell-mediated pure red-cell aplasia in systemic lupus erythematosus: response to cyclosporin A and mycophenolate mofetil. Am J Hematol 78(2):161-163
11. Chan AY, Li EK, Tam LS, Cheng G, Choi PC (2005) Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with oral danazol and steroid. Rheumatol Int 25(5):388-390
12. Cossart YE, Field AM, Cant B, Widdows D (1975) Parvovirus-like particles in human sera. Lancet 1(7898):72-73
13. Meyer O (2003) Parvovirus B19 and autoimmune diseases. Joint Bone Spine 70(1):6-11
14. Meyer O, Kahn MF, Grossin M, Ribard P, Belmatoug N, Morinet F et al (1991) Parvovirus B19 infection can induce histiocytic necrotizing lymphadenitis (Kikuchi's disease) associated with systemic lupus erythematosus. Lupus 1(1):37-41
15. Seve P, Ferry T, Koenig M, Cathebras P, Rousset H, Broussolle C (2005) Lupus-like presentation of parvovirus B19 infection. Semin Arthritis Rheum 34(4):642-648